These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30071380)

  • 1. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
    Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
    Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.
    Li TF; Xu YH; Li K; Wang C; Liu X; Yue Y; Chen Z; Yuan SJ; Wen Y; Zhang Q; Han M; Komatsu N; Zhao L; Chen X
    Acta Biomater; 2019 Mar; 86():381-394. PubMed ID: 30654213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
    J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-mediated chemotherapy drug delivery in glioblastoma.
    Wang C; Li K; Li T; Chen Z; Wen Y; Liu X; Jia X; Zhang Y; Xu Y; Han M; Komatsu N; Zhao L; Chen X
    Nanomedicine (Lond); 2018 Jan; 13(2):157-178. PubMed ID: 29173008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes.
    Chen Z; Yuan SJ; Li K; Zhang Q; Li TF; An HC; Xu HZ; Yue Y; Han M; Xu YH; Komatsu N; Zhao L; Chen X
    J Control Release; 2020 Apr; 320():469-483. PubMed ID: 31987922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates.
    Chen Z; Wang C; Li TF; Li K; Yue Y; Liu X; Xu HZ; Wen Y; Zhang Q; Han M; Komatsu N; Xu YH; Zhao L; Chen X
    Nanomedicine (Lond); 2019 Feb; 14(3):335-351. PubMed ID: 30676239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice.
    Ouyang J; Jiang Y; Deng C; Zhong Z; Lan Q
    Int J Nanomedicine; 2021; 16():4105-4115. PubMed ID: 34163162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
    Xu HZ; Li TF; Wang C; Ma Y; Liu Y; Zheng MY; Liu ZJ; Chen JB; Li K; Sun SK; Komatsu N; Xu YH; Zhao L; Chen X
    J Nanobiotechnology; 2021 Sep; 19(1):268. PubMed ID: 34488792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
    van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
    FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
    Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
    J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
    Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
    Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections.
    Gutierrez-Corbo C; Dominguez-Asenjo B; Vossen LI; Pérez-Pertejo Y; Muñoz-Fenández MA; Balaña-Fouce R; Calderón M; Reguera RM
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28683183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-triggered intelligent drug delivery and anti-cancer photodynamic therapy using platelets as the vehicle.
    Li QR; Xu HZ; Xiao RC; Liu B; Ma TQ; Yu TT; Li LG; Wang MF; Zhao L; Chen X; Li TF
    Platelets; 2023 Dec; 34(1):2166677. PubMed ID: 36719251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
    Dragojevic S; Mackey R; Raucher D
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.